Search Results

There are 30451 results for: content related to: Generics, chemisimilars and biosimilars: is clinical testing fit for purpose?

  1. You have full text access to this OnlineOpen article
    Biosimilars advancements: Moving on to the future

    Biotechnology Progress

    Volume 31, Issue 5, September/October 2015, Pages: 1139–1149, Lilian Rumi Tsuruta, Mariana Lopes dos Santos and Ana Maria Moro

    Version of Record online : 16 MAR 2015, DOI: 10.1002/btpr.2066

  2. Regulatory Strategies and Lessons in the Development of Biosimilars

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Umang S. Shah

    Published Online : 25 NOV 2013, DOI: 10.1002/9780470571224.pse511

  3. The State of the Art in the Development of Biosimilars

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 3, March 2012, Pages: 405–417, Mark McCamish and Gillian Woollett

    Version of Record online : 8 FEB 2012, DOI: 10.1038/clpt.2011.343

  4. You have full text access to this OnlineOpen article
    Biosimilar granulocyte–colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?

    Transfusion

    Volume 55, Issue 2, February 2015, Pages: 430–439, Halvard Bonig, Petra S. Becker, Arnd Schwebig and Matthew Turner

    Version of Record online : 26 JUN 2014, DOI: 10.1111/trf.12770

  5. You have free access to this content
    Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implications

    Diabetes, Obesity and Metabolism

    Volume 18, Issue 8, August 2016, Pages: 737–746, H. A. Dowlat, M. K. Kuhlmann, H. Khatami and F. J. Ampudia-Blasco

    Version of Record online : 20 MAY 2016, DOI: 10.1111/dom.12676

  6. You have full text access to this OnlineOpen article
    Biosimilars 101: considerations for U.S. oncologists in clinical practice

    Cancer Medicine

    Volume 3, Issue 4, August 2014, Pages: 889–899, Luis H. Camacho, Craig P. Frost, Esteban Abella, Phuong K. Morrow and Sadie Whittaker

    Version of Record online : 8 MAY 2014, DOI: 10.1002/cam4.258

  7. You have free access to this content
    Biosimilar: what it is not

    British Journal of Clinical Pharmacology

    Volume 80, Issue 5, November 2015, Pages: 949–956, Fernando de Mora

    Version of Record online : 4 JUN 2015, DOI: 10.1111/bcp.12656

  8. Biosimilar Development: Nonclinical and Clinical Strategies and Challenges with a Focus on the Role of PK/PD Assessments

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Susan Hurst and Donghua Yin

    Published Online : 30 DEC 2015, DOI: 10.1002/9780470571224.pse557

  9. You have full text access to this OnlineOpen article
    Biosimilar insulins: a European perspective

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 5, May 2015, Pages: 445–451, J. H. DeVries, S. C. L. Gough, J. Kiljanski and L. Heinemann

    Version of Record online : 27 NOV 2014, DOI: 10.1111/dom.12410

  10. Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation

    The Journal of Clinical Pharmacology

    Volume 55, Issue S3, March 2015, Pages: S123–S132, Bradley J. Scott, Agnes V. Klein and Jian Wang

    Version of Record online : 26 JUN 2014, DOI: 10.1002/jcph.339

  11. Biosimilars: how similar?

    Internal Medicine Journal

    Volume 44, Issue 3, March 2014, Pages: 218–223, V. Strand and B. Cronstein

    Version of Record online : 13 MAR 2014, DOI: 10.1111/imj.12292

  12. Analytical strategies for assessing comparability of biosimilars

    Journal of Chemical Technology and Biotechnology

    Volume 86, Issue 7, July 2011, Pages: 915–922, Robert J. Falconer, Dianne Jackson-Matthews and Stephen M. Mahler

    Version of Record online : 26 APR 2011, DOI: 10.1002/jctb.2629

  13. You have free access to this content
    Biosimilars in psoriasis: What can we expect?

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 12, Issue 4, April 2014, Pages: 306–312, Marc Alexander Radtke and Matthias Augustin

    Version of Record online : 2 APR 2014, DOI: 10.1111/ddg.12294

  14. You have full text access to this OnlineOpen article
    Biosimilar agents in oncology/haematology: from approval to practice

    European Journal of Haematology

    Volume 86, Issue 4, April 2011, Pages: 277–288, Dietger Niederwieser and Stephan Schmitz

    Version of Record online : 25 JAN 2011, DOI: 10.1111/j.1600-0609.2010.01566.x

  15. Scientific considerations for assessing biosimilar products

    Statistics in Medicine

    Volume 32, Issue 3, 10 February 2013, Pages: 370–381, Shein-Chung Chow, Jun Wang, Laszlo Endrenyi and Peter A. Lachenbruch

    Version of Record online : 30 AUG 2012, DOI: 10.1002/sim.5571

  16. You have free access to this content
    Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America

    The Journal of Dermatology

    Volume 44, Issue 1, January 2017, Pages: 3–12, Claudia de la Cruz, André V. E. de Carvalho, Gladys L. Dorantes, Angela M. Londoño Garcia, Cesar Gonzalez, Matías Maskin, Nancy Podoswa, Jan S. Redfern, Fernando Valenzuela, Joelle van der Walt and Ricardo Romiti

    Version of Record online : 27 JUL 2016, DOI: 10.1111/1346-8138.13512

  17. Medical specialists' attitudes to prescribing biosimilars

    Pharmacoepidemiology and Drug Safety

    Amy Hemmington, Nicola Dalbeth, Paul Jarrett, Alan G. Fraser, Reuben Broom, Peter Browett and Keith J. Petrie

    Version of Record online : 24 FEB 2017, DOI: 10.1002/pds.4186

  18. You have free access to this content
    Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 10, November 2015, Pages: 1158–1169, K. Papamichael, T. Van Stappen, V. Jairath, K. Gecse, R. Khanna, G. D'Haens, S. Vermeire, A. Gils, B. G. Feagan, B. G. Levesque and N. Vande Casteele

    Version of Record online : 13 SEP 2015, DOI: 10.1111/apt.13402

  19. New frontiers in cell line development: challenges for biosimilars

    Journal of Chemical Technology and Biotechnology

    Volume 86, Issue 7, July 2011, Pages: 895–904, Jeff Jia Cheng Hou, Joe Codamo, Warren Pilbrough, Benjamin Hughes, Peter P Gray and Trent P Munro

    Version of Record online : 15 FEB 2011, DOI: 10.1002/jctb.2574

  20. Biosimilar Drugs

    Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications, Second Edition

    Oliver Kayser, Heribert Warzecha, Pages: 285–335, 2012

    Published Online : 17 APR 2012, DOI: 10.1002/9783527632909.ch13